The issue of antimicrobial resistance in human medicine

被引:57
作者
Beovic, Bojana [1 ]
机构
[1] Univ Ljubljana, Med Ctr, Dept Infect Dis, Ljubljana 1525, Slovenia
关键词
antibiotics; bacteria; antibiotic resistance; human medicine; agriculture;
D O I
10.1016/j.ijfoodmicro.2006.05.001
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Antibiotics are used worldwide in human medicine and agriculture. In many cases the use of antibiotics is unnecessary or questionable. Consumption of antibiotics is linked to bacterial resistance. In hospitals, most common resistant bacteria include methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and Gram-negative rods including Enterobacteriaceae and Pseudomonas aeruginosa. Vancomycin intermediate and resistant S. aureus, described just recently, represent a new treatment challenge. In the community, penicillin and macrolide-resistant pneumococci developed several decades ago and are now present all over the world. More recently, community-acquired methicillin-resistant S. aureus has become a problem in several countries causing skin infections but also severe diseases. Resistance to co-trimoxazole in Escherichia coli has changed empirical treatment of urinary tract infections, one of the most common causes of the visit to the physician's office. Several reports and studies trying to limit the use of antibiotics have shown that antimicrobial resistance of bacteria can be reversed, but in general the problem is far from being solved. World Health Assembly and the European Community Council have recognized the problem of antibiotic resistance as a priority. The relationship between agricultural use of antimicrobials and antibacterial resistance in humans should be further investigated. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:280 / 287
页数:8
相关论文
共 83 条
[1]  
ALURENCE DR, 1997, CLIN PHARM, P3
[2]   Dissemination amongst humans and food products of animal origin of a Salmonella typhimurium clone expressing an integron-borne OXA-30 β-lactamase [J].
Antunes, P ;
Machado, J ;
Sousa, JC ;
Peixe, L .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (02) :429-434
[3]  
Arason VA, 1996, BMJ-BRIT MED J, V313, P387
[4]   Antibiotic resistance - Squeezing the balloon? [J].
Burke, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (14) :1270-1271
[5]   The use and resistance to antibiotics in the community [J].
Cizman, M .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 21 (04) :297-307
[6]   Antibiotic policies in Central Eastern Europe [J].
Cizman, M ;
Beovic, B ;
Krcmery, V ;
Barsic, B ;
Tamm, E ;
Ludwig, E ;
Pelemis, M ;
Karovski, K ;
Grzesiowski, P ;
Gardovska, D ;
Volokha, A ;
Keuleyan, E ;
Stratchounski, L ;
Dumitru, C ;
Titov, LP ;
Usonis, V ;
Dvorák, P .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 (03) :199-204
[7]  
COLEMAN RW, 1991, AM J MED, V90, P439
[8]   Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia:: A meta-analysis [J].
Cosgrove, SE ;
Sakoulas, G ;
Perencevich, EN ;
Schwaber, MJ ;
Karchmer, AW ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (01) :53-59
[9]   Quantifying human health risks from virginiamycin used in chickens [J].
Cox, LA ;
Popken, DA .
RISK ANALYSIS, 2004, 24 (01) :271-288
[10]  
Cunha Burke A, 2002, Semin Respir Infect, V17, P204, DOI 10.1053/srin.2002.34686